ODDB.org: Open Drug Database | Medikamente

Home - FI zu Fasigyn®

Fachinformation zu Fasigyn®:

Pfizer AG

Vollst. Fachinformation	DDD	Drucken
Gal.Form/Ther.Gr.	Zusammens.	Eigensch.	Pharm.kinetik	Ind./Anw.mögl.	Dos./Anw.	Anw.einschr.	Unerw.Wirkungen
Interakt.	Überdos.	Sonstige H.	Swissmedic-Nr.	Stand d. Info.

P01AB02 - Tinidazole

ATC-DDD Version 2016. Source: WHO

P - Antiparasitic Products, Insecticides and Repellents

The group is subdivided according to types of parasites.

P01 - Antiprotozoals

P01A - Agents Against Amoebiasis and Other Protozoal Diseases

This group comprises drugs mainly used for amoeba infections and other protozoal diseases such as giardiasis and trichomoniasis.

P01AB - Nitroimidazole Derivatives

Nitroimidazole derivatives used for amoebiasis, trichomoniasis and giardiasis are classified in this group. Formulations for vaginal administration are classified in G01AF. Parenteral formulations mainly used for treatment of anaerobic bacterial infections are classified in J01XD. Fixed combination packages for eradication of Helicobacter pylori are classified in A02BD.
Combinations with antibacterials are classified in J01R.

The DDDs are based on the treatment of amoebiasis, giardiasis and trichomoniasis. The duration of the treatment periods is not taken into consideration.

P01AB02 - Tinidazole

Stärke	Adm.Route	Note
	R
	O

2024	©ywesee GmbH